{
  "trial_id": "NCT02304302",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Cytogenetically documented Trisomy 21 or Complete Unbalanced Translocation of Chromosome 21",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No pregnancy by serum testing at screening",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Laboratory findings within normal limits or judged clinically insignificant at baseline",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Vital signs within normal limits for age",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "ECG must demonstrate predominately normal sinus rhythm",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Participants and their authorized representatives will provide written informed consent",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Participants who have received any experimental drug for Down syndrome must undergo a washout",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "All participants must: Be in general good health as judged by the investigators; Be able to swallow oral medication; Have a reliable caregiver or family member who agrees to accompany participant to all visits, provide information about the participant as required by the protocol, and ensure compliance with the medication schedule",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Age and gender matching participants without Down syndrome, must be: Males or females without Down syndrome aged-matching (within 3 years) participants with Down syndrome whom they are expected to serve as controls",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Participant weighing less than 40 kg",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Current psychiatric or neurologic diagnosis other than Down syndrome (e.g., major depressive disorder, schizophrenia, bipolar disorder, autism, Alzheimer disease)",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Current treatment with psychotropic drugs",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Drug or alcohol abuse or dependence",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Significant suicide risk or who would require treatment with electro-convulsive therapy or with psychotropic drugs during the study or who have received treatment with a depot neuroleptic drug within 6 months of entering the study.",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has CLL and large cell transformation, but no other significant medical history mentioned.",
  "_meta": {
    "topic_id": "8",
    "trial_id": "NCT02304302",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}